U-GILD

Q:GILD - GILEAD SCIENCES INC - http://www.gilead.com

17:31:34 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
GILD - Q	0.1	77.93	·	77.97	0.1	77.89	+1.68	2.2	4,877.2	375,288	30,374	76.19 77.985 75.80	89.74 57.165	17:09:16	Jun 01	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 30374

Date ET	Symbol	Type	Headline
2023-06-01 08:34	U:GILD	News Release200	Gilead and Kite Oncology Demonstrate Growing Hematology Pipeline and Strength of Leading Cell Therapy Portfolio at EHA
2023-05-26 01:00	U:GILD	News Release200	CHMP Adopts Positive Opinion to Extend the Use of Veklury ‚ ® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
2023-05-25 16:05	U:GILD	News Release200	Gilead Sciences to Present at Upcoming Investor Conference
2023-05-17 08:30	U:GILD	News Release200	Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023
2023-05-16 16:01	U:GILD	News Release200	Gilead Appoints Cindy Perettie Executive Vice President of Kite
2023-05-15 08:30	U:GILD	News Release200	Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation
2023-05-09 08:30	U:GILD	News Release200	Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera

Date ET

Symbol

Type

Headline

2023-06-01 08:34

News Release

2023-05-26 01:00

News Release